Fig. 8: The schematic diagram illustrates the mechanism of NGF in osteosarcoma metastasis.

NGF promotes MMP-2-dependent osteosarcoma cell migration by inhibiting the effects of miR-92a-1-5p through the MEK/ERK signaling cascade, while larotrectinib effectively suppresses NGF-induced cell migration.